XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 51662-1405
  • Package NDC 51662-1405-1
  • Package NDC 51662-1405-3
  • Application number NDA006488
  • SPL ID 0f8e16e6-1ad6-c2d7-e063-6394a90a12ff
  • SPL set ID 971439ed-4507-7a30-e053-2a95a90a1f1c
  • UNII EC2CNF7XFP
  • UNII 30Q7KI53AK
  • RxCUI 1867943

What the source publishes

Labeler
HF Acquisition Co LLC, DBA HealthFirst
Active ingredients
XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)
Form
INJECTION, SOLUTION
Routes
EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:51662-1405_0f8e16e6-1ad6-c2d7-e063-6394a90a12ff
{
  "name": "XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)",
  "splId": "0f8e16e6-1ad6-c2d7-e063-6394a90a12ff",
  "labels": [
    {
      "setId": "971439ed-4507-7a30-e053-2a95a90a1f1c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=971439ed-4507-7a30-e053-2a95a90a1f1c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=971439ed-4507-7a30-e053-2a95a90a1f1c"
    }
  ],
  "routes": [
    "EPIDURAL",
    "INFILTRATION",
    "INTRACAUDAL",
    "PERINEURAL"
  ],
  "labeler": "HF Acquisition Co LLC, DBA HealthFirst",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 mL in 1 VIAL, SINGLE-DOSE (51662-1405-1)",
      "package_ndc": "51662-1405-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191111"
    },
    {
      "sample": false,
      "description": "25 POUCH in 1 CASE (51662-1405-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1405-2)  / 30 mL in 1 VIAL, SINGLE-DOSE",
      "package_ndc": "51662-1405-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220317"
    }
  ],
  "productId": "51662-1405_0f8e16e6-1ad6-c2d7-e063-6394a90a12ff",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "51662-1405",
  "deaSchedule": null,
  "genericName": "XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS",
      "strength": "10 mg/mL"
    },
    {
      "name": "EPINEPHRINE BITARTRATE",
      "strength": ".005 mg/mL"
    }
  ],
  "applicationNumber": "NDA006488",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20191111",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0363323487072"
    ],
    "unii": [
      "EC2CNF7XFP",
      "30Q7KI53AK"
    ],
    "rxcui": [
      "1867943"
    ],
    "spl_set_id": [
      "971439ed-4507-7a30-e053-2a95a90a1f1c"
    ],
    "manufacturer_name": [
      "HF Acquisition Co LLC, DBA HealthFirst"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:51662-1405_0f8e16e6-1ad6-c2d7-e063-6394a90a12ff"